These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25857733)

  • 1. Development and evaluation of murine lung-specific disease models for Pseudomonas aeruginosa applicable to therapeutic testing.
    Lawrenz MB; Biller AE; Cramer DE; Kraenzle JL; Sotsky JB; Vanover CD; Yoder-Himes DR; Pollard A; Warawa JM
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25857733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of High-Dose Meropenem (Six Grams per Day) in Treatment of Experimental Murine Pneumonia Induced by Meropenem-Resistant Pseudomonas aeruginosa.
    Oshima K; Nakamura S; Iwanaga N; Takemoto K; Miyazaki T; Yanagihara K; Miyazaki Y; Mukae H; Kohno S; Izumikawa K
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
    Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
    Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem.
    Bretonnière C; Jacqueline C; Caillon J; Guitton C; Le Mabecque V; Miégeville AF; Villers D; Potel G; Boutoille D
    J Antimicrob Chemother; 2010 Nov; 65(11):2423-7. PubMed ID: 20858688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ceftolozane in a murine model of Pseudomonas aeruginosa acute pneumonia: in vivo antimicrobial activity and impact on host inflammatory response.
    Jacqueline C; Roquilly A; Desessard C; Boutoille D; Broquet A; Le Mabecque V; Amador G; Potel G; Caillon J; Asehnoune K
    J Antimicrob Chemother; 2013 Jan; 68(1):177-83. PubMed ID: 22941899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia.
    Chen C; Deslouches B; Montelaro RC; Di YP
    Clin Microbiol Infect; 2018 May; 24(5):547.e1-547.e8. PubMed ID: 28882728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections.
    Castón JJ; De la Torre Á; Ruiz-Camps I; Sorlí ML; Torres V; Torre-Cisneros J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PcrV antibody protects multi-drug resistant Pseudomonas aeruginosa induced acute lung injury.
    Wang Q; Li H; Zhou J; Zhong M; Zhu D; Feng N; Liu F; Bai C; Song Y
    Respir Physiol Neurobiol; 2014 Mar; 193():21-8. PubMed ID: 24418353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa.
    Nakamura A; Miyake K; Misawa S; Kuno Y; Horii T; Kondo S; Tabe Y; Ohsaka A
    J Hosp Infect; 2013 Feb; 83(2):153-5. PubMed ID: 23201400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model.
    Thomsen K; Christophersen L; Bjarnsholt T; Jensen PØ; Moser C; Høiby N
    J Cyst Fibros; 2016 Mar; 15(2):171-8. PubMed ID: 26303991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.
    Gellatly SL; Hancock RE
    Pathog Dis; 2013 Apr; 67(3):159-73. PubMed ID: 23620179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term effect of erythromycin therapy on Pseudomonas aeruginosa in chronic murine model of pseudomonas pulmonary infection].
    Nagata T; Mukae H; Kadokawa T; Kaida H; Kuroki M; Yanagihara K; Asano K; Kadota J; Koji T; Kawano S
    Jpn J Antibiot; 2003 Apr; 56 Suppl A():57-9. PubMed ID: 14679749
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.
    Maurice NM; Bedi B; Sadikot RT
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):428-439. PubMed ID: 29372812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin.
    Hamer DH
    Am J Respir Crit Care Med; 2000 Jul; 162(1):328-30. PubMed ID: 10903263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas-Induced Pneumonia.
    Birkun AA; Kubyshkin AV; Novikov NY; Krivorutchenko YL; Fedosov MI; Postnikova ON; Snitser AA
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):299-307. PubMed ID: 25517041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
    Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
    Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kwa AL; Loh C; Low JG; Kurup A; Tam VH
    Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.